2012
DOI: 10.1016/j.ejphar.2012.09.049
|View full text |Cite
|
Sign up to set email alerts
|

Docosahexaenoic acid, an omega-3 polyunsaturated acid protects against indomethacin-induced gastric injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
22
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 23 publications
(25 citation statements)
references
References 20 publications
2
22
1
Order By: Relevance
“…Indeed, omega-3 may increase bleeding (Clarke et al, 1990;Mozaffarian & Wu, 2011) but they have also gastro-protective effects in doses of 5-10 ml/kg in animal models with gastric ulcers induced by various agents, including dexamethasone (Bhattacharya et al, 2006;Faust et al, 1989;Manjari & Das, 2000;Pineda-Pena et al, 2012). The observations in the present case study seem at first conflicting to the above mentioned gastroprotective effects of omega-3 fatty acids.…”
Section: Reflectionscontrasting
confidence: 61%
“…Indeed, omega-3 may increase bleeding (Clarke et al, 1990;Mozaffarian & Wu, 2011) but they have also gastro-protective effects in doses of 5-10 ml/kg in animal models with gastric ulcers induced by various agents, including dexamethasone (Bhattacharya et al, 2006;Faust et al, 1989;Manjari & Das, 2000;Pineda-Pena et al, 2012). The observations in the present case study seem at first conflicting to the above mentioned gastroprotective effects of omega-3 fatty acids.…”
Section: Reflectionscontrasting
confidence: 61%
“…Earlier studies reported beneficial effect of polyunsaturated fatty acids such as DHA, linoleic acid, and g-linolenic acid in ulcer relief, including NSAID-induced ulcers (alShabanah, 1997;Pineda-Peña et al, 2012). The beneficial effects of these fatty acids in ulcer models could be attributable in part to their epoxide metabolites, as suggested by this study.…”
Section: Discussionsupporting
confidence: 48%
“…Although a recent systematic review does not allow firm recommendations about the usefulness of n-3 PUFA dietary supplements in IBD (52), other works, especially at the preclinical stage, suggest that n-3 PUFAs or their lipid-derived mediators might have a therapeutic effect (19)(20)(21)53). Indeed, the n-3 PUFAs DHA and EPA, found in fish oils, are extensively used currently as dietary supplements and are thought to exert beneficial effects in a number of inflammationrelated diseases (54,55) and in different experimental models (53,56,57). More recently, EPA and DHA lipid-derived mediators known as resolvins and protectins have been described as key mediators in the resolution of inflammation and regulators of normal homeostasis (5,9).…”
Section: Discussionmentioning
confidence: 99%